D-Glutamate

D-Glutamate

SCHEMBL4531315

C[C@H](N)C(=O)O.NC(CCC(=O)O)C(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.82
GRM8 O00222 2/20 0.82
GRM6 O15303 2/20 0.82
GRM7 Q14831 2/20 0.82
GRM4 Q14833 2/20 0.82
GRIN2D O15399 1/20 0.82
GRIN3B O60391 1/20 0.82
GSR P00390 1/20 0.82
GRIK1 P39086 1/20 0.82
GRM5 P41594 1/20 0.82
GRIA1 P42261 1/20 0.82
GRIA2 P42262 1/20 0.82
GRIA3 P42263 1/20 0.82
SLC1A3 P43003 1/20 0.82
SLC1A2 P43004 1/20 0.82
SLC1A1 P43005 1/20 0.82
GRIA4 P48058 1/20 0.82
GRIN1 Q05586 1/20 0.82
GRIN2A Q12879 1/20 0.82
GRIK2 Q13002 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL29406755 1.00 CYP1A2 (0.82) CYP1A2GRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL4531318 1.00 CYP1A2 (0.82) CYP1A2GRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL8637356 1.00 CYP1A2 (0.82) CYP1A2GRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL1444866 1.00 CYP1A2 (0.82) CYP1A2GRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL1444865 1.00 CYP1A2 (0.82) CYP1A2GRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL16241513 0.98 CYP1A2 (0.78) CYP1A2GRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL9679295 0.94 CYP1A2 (0.72) CYP1A2GRM8GRM6GRM7GRM4
Glutamic Acid SCHEMBL1963375 0.94 CYP1A2 (0.72) CYP1A2GRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL9679290 0.94 CYP1A2 (0.72) CYP1A2GRM8GRM6GRM7GRM4
D-Glutamate SCHEMBL1963374 0.94 CYP1A2 (0.72) CYP1A2GRM8GRM6GRM7GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed